A single center retrospective study on real world CAR T-cell therapy: focus on early hematological toxicity

Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL) and multiple myeloma have poor outcomes. CAR-T completely changed the landscape of therapy options, improving not only response rates but also survival outcomes. Hematological toxicity after chimeric...

Full description

Saved in:
Bibliographic Details
Main Authors: Vadim Lesan, Konstantinos Christofyllakis, Moritz Bewarder, Lorenz Thurner, Jörg Bittenbring
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1465802/full
Tags: Add Tag
No Tags, Be the first to tag this record!